A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents
about
Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsyNew advances in models and strategies for developing anti-obesity drugs.Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious miceObesity pharmacotherapy: what is next?NPY receptors as potential targets for anti-obesity drug development.Effect of blockade of neuropeptide Y receptor on aortic intima-media thickness and adipose tissue characteristics in normal and obese mice.Ligands of the neuropeptide Y Y2 receptor.Gut hormones: the future of obesity treatment?Strategies for preventing type 2 diabetes: an update for clinicians.PYY(3-36) into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake.Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance.Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity.Using peptides to study protein-protein interactions.The role of peptide YY in appetite regulation and obesity.Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier.Antiobesity Effect of a Short-Length Peptide YY Analogue after Continuous Administration in Mice.A Short-Length Peptide YY Analogue with Anorectic Effect in Mice.
P2860
Q26859135-A4CD930D-2F54-4C76-80AB-A14E25A8B718Q30429816-7A0BCBFD-9F3D-45D5-B327-CC91D5D00F18Q33589013-7B140EFA-3C6F-4E05-BC8C-663F23FAFD28Q33827988-FDD2C210-A82D-43EB-861A-9D078A72D708Q35130522-788A0B31-90DC-4519-86B4-A5B83DE5BB81Q35763438-72AE7DF2-DCE8-45D0-9D1C-917CFBB30FD1Q36355133-4F506379-20CF-423A-9A7D-BD7D64442EA7Q36468102-F3E80C23-6D66-4E2F-9A67-220A0F3D883AQ37117608-3F46FF5A-F0CB-4528-A34D-7CC071423CA6Q37138280-62E664F0-4CE5-42FB-AF2A-C894C0BA2CDFQ37173342-D73214B7-4ECC-47AA-B4A7-1EEC36692A7CQ37740010-7C01B3A0-1F69-49A9-B78C-DC71C05B4E6FQ37855887-D512749D-C3C1-4288-9F4F-34AF14A4161BQ48810891-6B1E49E0-02ED-419C-879F-9D9DD8A0EE7BQ50887481-A1ABF449-EDCA-411F-BD16-51748F5B6547Q54913313-7725D99D-A870-49B9-9D73-1313DCA86EE3Q55656124-FA1B8ABC-1F07-47CE-807C-BD7A3A1E95B3
P2860
A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents
description
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/11/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/11/01)
@nl
наукова стаття, опублікована в листопаді 2007
@uk
مقالة علمية (نشرت في نوفمبر 2007)
@ar
name
A novel long-acting selective ...... glucose metabolism in rodents
@ast
A novel long-acting selective ...... glucose metabolism in rodents
@en
A novel long-acting selective ...... glucose metabolism in rodents
@nl
type
label
A novel long-acting selective ...... glucose metabolism in rodents
@ast
A novel long-acting selective ...... glucose metabolism in rodents
@en
A novel long-acting selective ...... glucose metabolism in rodents
@nl
prefLabel
A novel long-acting selective ...... glucose metabolism in rodents
@ast
A novel long-acting selective ...... glucose metabolism in rodents
@en
A novel long-acting selective ...... glucose metabolism in rodents
@nl
P2093
P356
P1476
A novel long-acting selective ...... glucose metabolism in rodents
@en
P2093
Astrid A. Ortiz
Cathy D. Mahle
James N. Livingston
Kevin J. Lumb
Lucinda F. Milardo
Lynn B. DeCarr
Michelle R. Mays
Thomas H. Claus
Thomas M. Buckholz
P304
P356
10.1124/JPET.107.125211
P407
P577
2007-11-01T00:00:00Z